ALNYLAM PHARMACEUTICALS, INC. Gain Contingency, Patents Found Not Infringed upon, Number
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Gain Contingency, Patents Found Not Infringed upon, Number of 2 patent for the 12-month period ending 2023-12-31, per its 10-Q filed 2025-07-31.
Financial Statements › Income Statement › Other Income
us-gaap:GainContingencyPatentsFoundNotInfringedUponNumber · last filed 2025-07-31
| Period end | Gain Contingency, Patents Found Not Infringed upon, Number | Gain Contingency, Patents Found Not Infringed upon, Number 12 month |
|---|---|---|
| 2023-12-31 | 2.00 patent 10-Q · filed 2025-07-31 | |
| 2023-08-30 | 2.00 patent 10-Q · filed 2025-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |